Milestone scientific achieves 22% increase in revenue for the third quarter of 2024

Reports 57% increase in international dental sales for the third quarter of 2024 advances commercial rollout of compuflo® epidural system across additional pain management clinics following medicare price assignment in multiple u.s. states roseland, n.j., nov. 14, 2024 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported financial results for the third quarter ended september 30, 2024.
MLSS Ratings Summary
MLSS Quant Ranking